ipamorelin / cjc1295 CJC-1295 in Houston CJC-1295 No DAC + Ipamorelin

doi: 10.1016/j.exer.2007.04.004 123 StreeteIMJamieJFTruscottRJW

Sun, C., Feng, L., Zhang, Y., Xiao, L., Pan, W., Li, C., Zhang, L

Cell 5299309

Side Effects & Safety Mild GI discomfort most common, usually transient in the first week Slight stimulant effect increased energy/alertness, especially early on Headaches occasional, typically mild and dose-related Mild insomnia if taken too late in the day No human clinical safety data all safety information from preclinical studies and community reports No liver toxicity observed in animal studies at therapeutic doses Unknown drug interactions theoretically could interact with NAD+-dependent pathways Core Supplies for This Protocol The three essentials for running any reconstituted injectable: cold storage, accurate syringes, and metabolic tracking